Updates in Chronic Spontaneous Urticaria From EADV: Experts Highlight the Latest Advances

Updates in Chronic Spontaneous Urticaria From...

Up next

Pharmacological and Combination Interventions for Nicotine Cessation

Master the latest evidence-based meds and dual therapies to help your patients quit for good. Credit available for this activity expires: 06/25/2027 Earn Credit / Learning Objectives & Disclosures: https://www.staging.medscape.org/viewarticle/pharmacological-and-combination-inter ...  Show more

Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?

Is sustained hemostatic normalization achievable across all hemophilia A patients? Examine the evidence behind today's therapeutic advances. Credit available for this activity expires: 6/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/n ...  Show more

Recommended Episodes

Hot Topics in Atrial Fibrillation
Hot Topics in Cardiology

Listen in as experts discuss the latest updates in AFib management. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/963752?src=mkm_podcast_addon_963752 

EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies
Keeping Current CME

Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Lea ...  Show more

Milestones in IgAN & FSGS: Advancing Understanding and Possibilities
Life as a Nephrology Professional

Join us for an insightful podcast exploring the latest milestones in the understanding and treatment of IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Discover how recent breakthroughs in our understanding of these conditions are advancing clinical research ...  Show more

E44: Editor’s Picks November 2021
EADV Podcast

Join us as we go through the JEADV Editor's Picks of November 2021: (1) Long-term safety data for a monoclonal antibody used in psoriasis (2) Preventing anaphylactoid symptoms following Covid-19 vaccination (3) Innovative surgery option for bromhidrosis (4) Surprising trends in s ...  Show more